Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10
Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are characterized by excessive triglyceride accumulation in the liver. However, due to an incomplete understanding of its pathogenesis, more efforts are needed to i...
Збережено в:
| Автори: | , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2024-11-01
|
| Серія: | Molecular Metabolism |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2212877824001613 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|